Pilot clinical trials of FSPG (BAY 94-9392): An 18F-labeled glutamate derivative for PET imaging of system xCactivity in tumors

被引：0

作者：

Baek, Sora ^{[1
]}

Mittra, Erik ^{[2
]}

Cho, Chang -Min ^{[1
]}

Gong, Gyungyub ^{[1
]}

Oh, Seung Jun ^{[1
]}

Mosci, Camila ^{[2
]}

Kumar, Meena ^{[2
]}

Chin, Frederick T. ^{[2
]}

Fels, Lueder M. ^{[3
]}

Stephens, Andrew W. ^{[3
]}

Koglin, Norman ^{[3
]}

Mueller, Andre ^{[3
]}

Dinkelborg, Ludger M. ^{[3
]}

Moon, Dae Hyuk ^{[1
]}

Gambhir, Sanjiv S. ^{[2
]}

机构：

[1] ASAN Med Ctr, Seoul, South Korea

[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA

[3] Bayer HealthCare, Berlin, Germany

来源：

CANCER RESEARCH | 2012年 / 72卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：1

共 50 条

[1] Pilot clinical trials of FSPG (BAY 94-9392): An 18F-labeled glutamate derivative for PET imaging of system xC-activity in tumors
Baek, Sora
Mittra, Erik
Choi, Chang-Min
Gong, Gyungyub
Oh, Seung Jun
Mosci, Camila
Kumar, Meena
Chin, Frederick T.
Fels, Lueder M.
Stephens, Andrew W.
Koglin, Norman
Mueller, Andre
Dinkelborg, Ludger M.
Moon, Dae Hyuk
Gambhir, Sanjiv S.
CANCER RESEARCH, 2012, 72
[2] Evaluation of the 18F-labeled L-glutamate derivative 18F-FSPG (BAY 94-9392) in brain and head and neck cancer patients
Kumar, Meena
Mosci, Camila
Keu, Khun Visith
Iagaru, Andrei
Koglin, Norman
Fels, Lueder
Bacher-Stier, Claudia
Chin, Frederick
Gambhir, Sanjiv
Mittra, Erik
JOURNAL OF NUCLEAR MEDICINE, 2012, 53
[3] Evaluation of the 18F L-glutamate derivative 18F-FSPG (BAY 94-9392) in lymphoma and colon cancer patients
Kumar, Meena
Mosci, Camila
Keu, Khun Visith
Iagaru, Andrei
Koglin, Norman
Fels, Lueder
Bacher-Stier, Claudia
Chin, Frederick
Gambhir, Sanjiv
Mittra, Erik
JOURNAL OF NUCLEAR MEDICINE, 2012, 53
[4] Studies of the 18F L-glutamate derivative BAY 94-9392 in cancer patients: A novel radiopharmaceutical for PET imaging
Mittra, Erik
Mosci, Camila
Iagaru, Andrei
Fels, Luder
Bacher-Stier, Claudia
Chin, Frederick
Gambhir, Sanjiv
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[5] BAY 94-9392: A novel F-18 labeled tumor specific probe for PET/CT imaging - Dosimetry
Smolarz, Kamilla
Krause, Bernd Joachim
Graner, Frank-Philipp
Wagner, Franziska
Bacher-Stier, Claudia
Sparks, Rick
Ramsay, Susan
Fels, Lueder
Dinkelborg, Ludger
Schwaiger, Markus
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[6] First Experience with Bay 94-9392, a Novel F-18 L-glutamate Derivative, for PET/CT Imaging in Patients with Hepatocellular Cancer
Baek, S.
Lim, Y. S.
Lee, H. C.
Lee, Y.
Kim, J. S.
Koglin, N.
Fels, L.
Bacher-Stier, C.
Moon, D. H.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S182 - S182
[7] Tumor-specific PET Imaging Using BAY 94-9392-a Novel F-18 Labeled L-Glutamate Derivative
Mueller, A.
Koglin, N.
Berndt, M.
Schmitt-Willich, H.
Rausch, A.
Gekeler, V.
Friebe, M.
Dinkelborg, L. M.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S180 - S180
[8] BAY 94-9392-A novel F-18 L-glutamate derivative for tumor-specific PET imaging
Koglin, Norman
Mueller, Andre
Berndt, Mathias
Schmitt-Willich, Heribert
Gekeler, Volker
Friebe, Matthias
Dinkelborg, Ludger
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[9] First experience with BAY 94-9392, a novel F-18 L-glutamate derivative, for PET/CT imaging in patients with non-small cell lung and breast cancer
Baek, Sora
Choi, Chang-Min
Ahn, Sei Hyun
Lee, Jong Won
Ryu, Jin-Sook
Oh, Seung Jun
Bacher-Stier, Claudia
Fels, Lueder
Dinkelborg, Ludger
Moon, Dae Hyuk
JOURNAL OF NUCLEAR MEDICINE, 2011, 52
[10] BAY 94-9392-A new derivative of L-glutamate for tumor specific PET imaging
Koglin, Norman
Mueller, Andre
Friebe, Matthias
Berndt, Mathias
Schmitt-Willich, Heribert
Gekeler, Volker
Dinkelborg, Ludger M.
CANCER RESEARCH, 2011, 71

← 1 2 3 4 5 →